Author:
Goldberg R.M.,Kaufmann S.H.,Atherton P.,Sloan J.A.,Adjei A.A.,Pitot H.C.,Alberts S.R.,Rubin J.,Miller L.L.,Erlichman C.
Reference52 articles.
1. Activity of CPT-11 (irinotecan hydrochloride), a topoisomerase I inhibitor, against human tumor colony-forming units;Shimada;Anticancer Drugs,1994
2. Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in a novel water-soluble derivative of camptothecin, against murine tumors;Kunimoto;Cancer Res,1987
3. Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice;Kawato;Cancer Chemother Pharmacol,1991
4. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer;Moertel;Cancer Chemother Rep,1972
5. Treatment of malignant melanoma with camptothecin (NSC-100880);Gottlieb;Cancer Chemother Rep,1972
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献